Photocure ASA

Earnings Release • Apr 29, 2015

Photocure ASA: Ipsen releases 1Q 2015 sales report

Photocure ASA: Ipsen releases 1Q 2015 sales report

Oslo, Norway, 29 April 2015: Photocure ASA (OSE: PHO), a specialty

pharmaceutical company focused on photodynamic technologies in dermatology and

cancer, refers to the first quarter 2015 report from Ipsen released today.

Photocure has a strategic partnership with Ipsen for the commercialization of

Hexvix® in Europe, excluding the Nordic region.

In the first quarter 2015, inventory reductions in first quarter 2014 and the

foreign exchange rate development contributed to a revenue increase from Ipsen

of 33%, compared to the first quarter 2014.

Photocure will release the first quarter 2015 interim report 6 May at 07.30

(CET). The report will be presented at Hotel Continental, Oslo, Norway, at

08.30 (CET).

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: +47 450 55 000, E-mail: ed@photocure.no

www.photocure.com

This information is subject to the disclosure requirements pursuant to section

5-12 of the Norwegian Securities Trading Act.

[HUG#1916081]